PRESS RELEASE published on 05/25/2023 at 15:17, 3 years 3 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2023
PRESS RELEASE published on 05/05/2023 at 12:25, 3 years 4 months ago Heidelberg Pharma appoints Chief Financial Officer
PRESS RELEASE published on 04/13/2023 at 07:10, 3 years 5 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
PRESS RELEASE published on 04/04/2023 at 10:12, 3 years 5 months ago Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
PRESS RELEASE published on 03/24/2023 at 07:11, 3 years 5 months ago Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
Published on 09/12/2026 at 02:35, 1 day 19 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 22 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 4 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 14 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 23 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 23 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 2 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 2 hours ago Availability of the 2026 Interim Financial Report
